Sustainable Development
Discover our 'Sustainable Development - For Generations' journey. The journey not only involves the current generation but future ones to come.
Search
Media Overview
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. Click here for a media overview.
PCI with stenting animation
Atrial fibrillation (AF) is the most common cardiac rhythm disorder worldwide. Click here for more information on Stroke Prevention in atrial fibrillation.
UK donates to vulnerable children and local emergency fund
Find out how colleagues in the UK are helping disadvantaged young people in isolation, and supporting charities in the community. Click here to learn more.
Our History
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies. Click here to learn more information about our history.
Co-creation with Communities
Making More Health has launched co-creation projects in Asia, Africa, Europe and other localities around the world with top social entrepreneurs.
Circular economy
Plastic pollution is one of the most serious threats to the world’s oceans. Click here to find out how long it takes for garbage to dissolve in the oceans!
Company Video: Value through Innovation
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies. Click here to watch our company video and learn about us.
Improving Access to Healthcare
According to the UN Sustainable Development Goals, almost half of the global population is not covered by essential health services. Find out more.
Shanghai
Shanghai serves as an important hub for all of the company’s three business areas: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.
COVID-19: Global Support Program - Global
Here you can find out about our work to support countries across the world during the pandemic. Click here to find out and learn more about the support.
Connect with your heart
If you know someone who has type 2 diabetes, they are twice as likely to develop heart failure than those without. Click here to find out more.
BI India joins forces with PPAM and BMC to Stop Rabies
This initiative will adopt a two-pronged approach of vaccination and education.
Boehringer Ingelheim India recognized as Top Employer 2024
Boehringer Ingelheim India recognized as Top Employer 2024
Coronavirus in pets and humans: learn the differences
Coronavirus in pets and humans: learn the differences. To date, there is no evidence that dogs and cats can be infected or transmit COVID-19.
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
COVID-19 Supply Chain and Production
Supplying patients and customers with their medicines is our highest priority. Learn about COVID-19's impact on our supply chain and production here.
BI Access to Healthcare Strategy_Availability
Through our Access to Healthcare Strategy, we want to ensure that our compounds are readily and responsibly available. Learn more about our work here.
Living Independence
Boehringer Ingelheim’s corporate culture is based on values that have been applied since the company was founded in 1885. Click here to learn more.
Afrika Kommt! - The Ripple Effect
What the Afrika Kommt! Fellowship Program means to Boehringer Ingelheim
Dr. V. Mohan Releases 9-point Action for People with Diabetes
Dr V. Mohan has released a 9-point action plan to ensure health for people with diabetes. Click here to read the press release and find out more.
More Health Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations. Learn more.
Our Employees
We offer our employees demanding and challenging tasks. Boehringer Ingelheim needs employees who innovate. Learn more about our employees here.
Jardiance® (empagliflozin) now approved in India for treatment of chronic kidney disease
Jardiance® (empagliflozin) now approved in India
COVID-19 Bill and Melinda Gates Foundation
We are joining the COVID-19 Therapeutics Accelerator of the Bill and Melinda Gates Foundation to fight the pandemic. Click here to learn more.